Evercore ISI Sticks to Its Buy Rating for Hemab Therapeutics Holdings, Inc. (COAG)
at www.tipranks.com (Wed, 11-Nov 10:06 AM)
Hemab Therapeutics Holdings GAAP EPS of -$0.58 misses by $0.06
at seekingalpha.com (Tue, 10-Nov 7:24 AM)
COAG advances HMB-003 into Phase 1 with once-per-cycle dosing potential for heavy menstrual bleeding
Market Chameleon (Fri, 18-Sep 10:56 AM)
